JIA | sciencenewsnet.in

Breaking News

Kansas Proving Grounds Partners with SkyScoutAI Innovations Inc. to Deploy AI-Powered Drones for Wildfire Solution at America’s First Carbon Neutral Industrial Park

Perinatal Transmission of HIV Can Lead to Cognitive Deficits

CSUF Grad from Zimbabwe Aims to Improve Access to Mental Health Services

Alzheimer’s Consortium set to bring experts and families together at ASU

Critical Minerals Recovery from Electronic Waste

The Pediatric Emergency Department at Joseph M. Sanzari Children’s Hospital Becomes the First Autism Certified Center in the State

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

Landmark Conference Celebrating Betty Ford’s Legacy as First Lady, With Notable Expert Panels

New study points to racial and social barriers that block treatment for multiple myeloma

Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan

24 Apr, 2024

Early Combined Treatment with Biologic and Conventional DMARDs Could be Effective for Polyarticular Juvenile Arthritis

November 2, 2021 sarah JonasResearch Results

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.